{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:15:19Z","timestamp":1790702119652,"version":"4.1.0"},"reference-count":60,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The treatment of vitiligo is a persistent challenge in dermatology. New treatments are being offered and studied in this field for those resistant to or intolerant of classical therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>In this systematic review, we study the use of prostaglandin analogues (PGAs) and phosphodiesterase inhibitors (PDEIs) in the treatment of vitiligo, as they are known for their pigmentation inducing effects through activating melanocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched four main online databases with the keywords \u201cVitiligo\u201d, \u201cProstaglandin analogue\u201d and \u201cPhosphodiesterase inhibitor\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 42 articles were included, with 1027 cases, studying drugs like bimatoprost, latanoprost, travoprost, dinoprostone, apremilast, crisaborole, etc. Among the included studies, the treatment regimens are commonly once or twice daily for 12\u201348\u2009weeks, with a mean of 20.61\u2009weeks, and the routes of administration are mainly topical gels or ophthalmic solutions and oral tablets. Side effects are mild and tolerable, namely erythema, itching or burning sensations at application site for topicals, or gastrointestinal problems with apremilast. Repigmentation results are significant in both adult and pediatric patients and progressive or stable vitiligo. PGAs and PDEIs outperform many classical therapies, for example, narrowband ultraviolet B phototherapy (NB\u2010UVB), tacrolimus, mometasone or methylprednisolone mini\u2010pulse. PGAs or PDEIs are usually used in combination therapies to either cause synergism or increase drug delivery, and almost always enhance repigmentation, for example, with NB\u2010UVB, fractional CO<jats:sub>2<\/jats:sub> laser, microneedling, and mometasone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Monotherapy or add\u2010on PGAs and PDEIs can be considered effective treatments for vitiligo and promising last resorts for those resistant to other therapies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocd.16468","type":"journal-article","created":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T12:23:54Z","timestamp":1724070234000},"page":"3466-3487","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utility of prostaglandin analogues and phosphodiesterase inhibitors as promising last resorts for the treatment of vitiligo: A systematic review, from mechanisms of action to mono\u2010, combination and comparative therapies"],"prefix":"10.1111","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5393-0875","authenticated-orcid":false,"given":"Homa","family":"Pourriyahi","sequence":"first","affiliation":[{"name":"Student Research Committee, School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7705-7783","authenticated-orcid":false,"given":"Nastaran\u2010Sadat","family":"Hosseini","sequence":"additional","affiliation":[{"name":"School of Medicine Isfahan University of Medical Sciences  Isfahan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4340-3961","authenticated-orcid":false,"given":"Mohammadreza Padooiy","family":"Nooshabadi","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6025-8722","authenticated-orcid":false,"given":"Homayoun","family":"Pourriahi","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5070-5864","authenticated-orcid":false,"given":"Hamid Reza","family":"Baradaran","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health Iran University of Medical Sciences  Tehran Iran"},{"name":"Ageing Clinical and Experimental Research (ACER) Team Institute of Applied Health Sciences, University of Aberdeen  Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1081-9477","authenticated-orcid":false,"given":"Bahareh","family":"Abtahi\u2010Naeini","sequence":"additional","affiliation":[{"name":"Skin Diseases and Leishmaniasis Research Center Isfahan University of Medical Sciences  Isfahan Iran"},{"name":"Pediatric Dermatology Division of Department of Pediatrics, Imam Hossein Children's Hospital Isfahan University of Medical Sciences  Isfahan Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1249-4429","authenticated-orcid":false,"given":"Azadeh","family":"Goodarzi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences  Tehran Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2006.00355.x"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0298-5"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-020-03048-5"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00184"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2014.952610"},{"key":"e_1_2_14_7_1","first-page":"57","article-title":"Topical treatment and combination approaches for vitiligo: new insights, new developments","volume":"145","author":"Hossani\u2010Madani AR","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.00198.x"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15198"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20039"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14813"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12383"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08923.x"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2002.01612.x"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03346.x"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22516.x"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12985"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2386234"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1937710"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13176"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12904"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12443"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20198110"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6977"},{"key":"e_1_2_14_27_1","first-page":"350","article-title":"Three cases of vitiligo showing response to application of latanoprost","volume":"48","author":"Noh S","year":"2010","journal-title":"Korean Journal of Dermatology"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03677.x"},{"key":"e_1_2_14_29_1","article-title":"Apremilast is effective in controlling the progression and inducing repigmentation in adult vitiligo: A case series","volume":"12","author":"Majid I","year":"2020","journal-title":"J Dermatol Nurses Assoc"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12923"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13064"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.03.028"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2200873"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac092"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32591-8"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13648"},{"key":"e_1_2_14_37_1","first-page":"703","article-title":"Bimatoprost 0.03% solution for the treatment of nonfacial vitiligo","volume":"15","author":"Grimes PE","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14882"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13783"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.359"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1658860"},{"key":"e_1_2_14_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.12631"},{"key":"e_1_2_14_43_1","article-title":"The paradox of the effects of PGF2\u03b1 on pigmentation in\u00a0vivo and in\u00a0vitro","volume":"24","author":"Anbar TS","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"e_1_2_14_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13175"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-019-02900-7"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12363"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.134"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.36849\/jdd.5751"},{"key":"e_1_2_14_49_1","first-page":"470","article-title":"Comparative evaluation of therapeutic efficacy and safety of dermabrasion with PGE2 analogue (Dinoprostone), 5\u2010Flourouracil cream (5%) and Tacrolimus (0.1%) cream in localised stable vitiligo","volume":"34","author":"Kaur J","year":"2021","journal-title":"Pigment Cell and Melanoma Research"},{"key":"e_1_2_14_50_1","article-title":"Comparative evaluation of therapeutic efficacy and safety of apremilast versus oral methyl prednisolone mini pulse in unstable non segmental vitiligo","volume":"34","author":"Kaur J","year":"2021","journal-title":"Pigment Cell and Melanoma Research"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.20043"},{"key":"e_1_2_14_52_1","article-title":"Apremilast:a novel molecule in vitiligo","volume":"12","author":"Kumar S","year":"2020","journal-title":"J Dermatol Nurses Assoc"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.11.031"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02343-1"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.073"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12867"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14669"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15159"},{"key":"e_1_2_14_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14770"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.790125"},{"key":"e_1_2_14_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2018.1546043"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.16468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T05:15:54Z","timestamp":1730265354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.16468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1111\/jocd.16468"],"URL":"https:\/\/doi.org\/10.1111\/jocd.16468","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,19]]},"assertion":[{"value":"2024-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}